Literature DB >> 8839532

Hyperkalemia and digoxin toxicity in a patient with kidney failure.

F Fenton1, A J Smally, J Laut.   

Abstract

Hyperkalemia resulting from digoxin toxicity is a well-recognized phenomenon. We report a case in which hyperkalemia, bradycardia, and hypotension were unresponsive to standard therapy but appeared to respond to digoxin-specific antibodies (Fab). This case highlights the importance of a high index of suspicion for digoxin toxicity as a potential cause of refractory hyperkalemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8839532     DOI: 10.1016/s0196-0644(96)70012-4

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  6 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

2.  Case files of the medical toxicology fellowship of the California poison control system-San Francisco: calcium plus digoxin-more taboo than toxic?

Authors:  Christian P Erickson; Kent R Olson
Journal:  J Med Toxicol       Date:  2008-03

Review 3.  Acute Management of Hyperkalemia.

Authors:  Mengyang Liu; Zubaid Rafique
Journal:  Curr Heart Fail Rep       Date:  2019-06

Review 4.  Drug-induced hyperkalemia.

Authors:  Chaker Ben Salem; Atef Badreddine; Neila Fathallah; Raoudha Slim; Houssem Hmouda
Journal:  Drug Saf       Date:  2014-09       Impact factor: 5.606

5.  Current treatment and unmet needs of hyperkalaemia in the emergency department.

Authors:  Zubaid Rafique; Tahar Chouihed; Alexandre Mebazaa; W Frank Peacock
Journal:  Eur Heart J Suppl       Date:  2019-02-26       Impact factor: 1.803

Review 6.  Acute hyperkalemia in the emergency department: a summary from a Kidney Disease: Improving Global Outcomes conference.

Authors:  Gregor Lindner; Emmanuel A Burdmann; Catherine M Clase; Brenda R Hemmelgarn; Charles A Herzog; Jolanta Małyszko; Masahiko Nagahama; Roberto Pecoits-Filho; Zubaid Rafique; Patrick Rossignol; Adam J Singer
Journal:  Eur J Emerg Med       Date:  2020-10       Impact factor: 4.106

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.